Clinical Trials Browser

Phase 1 × Terminated × FANG vaccine × Clear all

NCT01258868 2019-12-03

Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas

Phase 1 Terminated

44 enrolled

GastrointestinalOther solid neoplasmThoracic

Esophageal Neoplasms, Lung Neoplasms, Mesothelioma, Thymoma

NCT00469820 2014-03-21

Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell Transplant

Phase 1 Terminated

1 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Congenital Abnormalities, Leukemia, Multiple Myeloma, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell

NCT00100971 2013-01-04

Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia

Phase 1 Terminated

9 enrolled

Other hematologic neoplasm

Congenital Abnormalities, Leukemia

NCT00098917 2008-01-28

Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer

Phase 1 Terminated

15 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms